Chronic care management startup Signos has raised USD 20 million in a Series B funding round. The round was led by Cheyenne Ventures and Google Ventures, with participation from Dexcom Ventures and Samsung Next. This brings the total funds raised by the company to USD 20 million.
The funding will be used to expand the company’s team and platform and conduct additional research on metabolic health. The platform includes an AI engine and continuous glucose monitor to provide real-time data and recommendations for healthy weight management.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.